COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 2034: Articles 20331-20340  | Next

Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells
Moghadasi, S. A., Becker, J. T., Belica, C., Wick, C., Brown, W. L., Harris, R.
10.1101/2020.11.09.375139 — Posted: 2020-11-09
Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome
Porritt, R. A., Paschold, L., Noval Rivas, M., Cheng, M. H., Yonker, L. M., Chandnani, H., Lopez, M., Simnica, D., Schultheiss, C., Santiskulvong, C., Van Eyk, J., Fasano, A., Bahar, I., Binder, M., Arditi, M.
10.1101/2020.11.09.372169 — Posted: 2020-11-09
Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma
Kfoury, N., Qi, Z., Prager, B. C., Wilkinson, M., Broestl, L., Berrett, K., Moudgil, A., Sankararaman, S., Chen, X., Gertz, J., Rich, J. N., Mitra, R., Rubin, J. B.
10.1101/199059 — Posted: 2020-11-09
Nafamostat Mesylate in lipid carrier for nasal SARS-CoV2 titer reduction in a hamster model
Cornelissen, L., Hoefsmit, E., Rao, D., Lijnsvelt, J., ven Keulen, L., van Es, M., Grimm, V., Medema, R. H., Blank, C. U.
10.1101/2020.11.09.372375 — Posted: 2020-11-09
Human coronaviruses disassemble processing bodies
Robinson, C.-A., Kleer, M., Mulloy, R. P., Castle, E. L., Boudreau, B. Q., Corcoran, J. A.
10.1101/2020.11.08.372995 — Posted: 2020-11-09 Discussion: Offsite
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
Laporte, M., Stevaert, A., Raeymaekers, V., Van Berwaer, R., Martens, K., Pöhlmann, S., Naesens, L.
10.1101/2020.11.09.374603 — Posted: 2020-11-09
Single cell transcriptomic re-analysis of immune cells in bronchoalveolar lavage fluids reveals the correlation of B cell characteristics and disease severity of patients with SARS-CoV-2 infection
Kim, C. W., Oh, J. E., Lee, H. K.
10.1101/2020.11.09.374272 — Posted: 2020-11-09
Resistance of endothelial cells to SARS-CoV-2 infection in vitro
Ahmetaj-Shala, B., Peacock, T. P., Baillon, L., Swann, O., Gashaw, H., Barclay, W. S., Mitchell, J. A.
10.1101/2020.11.08.372581 — Posted: 2020-11-09
Towards Targeting the Disordered SARS-CoV-2 Nsp2 C-terminal Region: Partial Structure and Dampened Mobility Revealed by NMR Spectroscopy
Mompean, M., Trevino, M. A., Laurents, D. V.
10.1101/2020.11.09.374173 — Posted: 2020-11-09
SARS-CoV-2 epitope mapping on microarrays highlights strong immune-response to N protein region
Musico, A., Frigerio, R., Mussida, A., Barzon, L., Sinigaglia, A., Riccetti, S., Gobbi, F., Piubelli, C., Bergamaschi, G., Chiari, M., Gori, A., Cretich, M.
10.1101/2020.11.09.374082 — Posted: 2020-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).